Document is current
Any future updates will be listed below
-
Authors
Wong, Elissa W. P.
Sahin, Merve https://orcid.org/0000-0003-3858-8332
Yang, Rui https://orcid.org/0000-0001-9358-9907
Lee, UkJin https://orcid.org/0000-0001-6644-4286
Li, Dan https://orcid.org/0000-0002-8777-4580
Zhan, Yingqian A.
Misra, Rohan https://orcid.org/0000-0002-6355-2764
Tomas, Fanny
Alomran, Nawaf
Polyzos, Alexander https://orcid.org/0000-0002-2509-9698
Lee, Cindy J.
Trieu, Tuan
Martinez-Fundichely, Alexander https://orcid.org/0000-0002-7660-5511
Wiesner, Thomas
Rosowicz, Andrew
Cheng, Shuyuan
Liu, Christina
Lallo, Morgan
Shoushtari, Alexander N. https://orcid.org/0000-0002-8065-4412
Merghoub, Taha https://orcid.org/0000-0002-1518-5111
Hamard, Pierre-Jacques https://orcid.org/0000-0002-2484-6161
Koche, Richard https://orcid.org/0000-0002-6820-5083
Khurana, Ekta https://orcid.org/0000-0002-4351-7566
Apostolou, Effie https://orcid.org/0000-0002-8111-0863
Zheng, Deyou https://orcid.org/0000-0003-4354-5337
Chen, Yu https://orcid.org/0000-0002-0171-3884
Leslie, Christina S. https://orcid.org/0000-0002-4571-5910
Chi, Ping https://orcid.org/0000-0002-0159-5531
- License Information
-
More Information
Article History
Received: 2 May 2023
Accepted: 20 May 2025
First Online: 30 June 2025
Competing interests
: Y.C. reports other support from Oric Pharmaceuticals and grants from Foghorn outside the submitted work. P.C. reports personal fees from Deciphera and Ningbo NewBay, grants and institutional support from Deciphera, Pfizer/Array and Ningbo NewBay, and personal fees from Zai Lab and Novartis outside the submitted work. The other authors declare no competing interests.
